ArticlePediatric research2026
Phosphoproteomic and kinase networks reveal partial EMT and stress-adaptive growth programs in pediatric Peutz-Jeghers polyps.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeutz-Jeghers syndrome (PJS) is a rare inherited cancer predisposing disorder associated with pathogenic variants of the Serine Threonine Kinase11 (STK11 / LKB1). Morbidity in children is driven by small intestinal obstruction from polyps. The molecular mechanisms driving polyp initiation and growth are poorly understood. We hypothesized that integrated phosphoproteomic analysis of pediatric Peutz-Jeghers polyps would reveal signaling networks driving polyp growth.
methodsIntestinal polyp and adjacent non-polyp mucosa from pediatric PJS patients undergoing therapeutic endoscopy-polypectomy underwent mass spectrometry-based proteomic and phosphoproteomic profiling. A bioinformatic pipeline and network analyses were performed to identify differential kinase activity, phosphopeptide enrichment, and signaling nodes relevant to polyp growth.
resultsPolyp tissue was enriched for proliferative signaling and biosynthetic drivers, including CLK1 and PKCβ, MAPK10, and MAPK11. Non-polyp mucosa however, exhibited higher expression of regulatory kinases such as HIPK2, PLK2, LATS1, STK38, and PRKCZ/PRKCI, reinforcing apoptosis, polarity, and Wnt/mTOR restraint. Phosphoproteomic networks in polyps support a partial epithelial-mesenchymal transition phenotype, amplified transcription and translation, and a survival shift from BAD-14-3-3 signaling toward YAP/mTOR/NF-kB.
conclusionsPJS polyps display a unique proteomic and phosphoproteomic signature that critically distinguishes PJS from other polyposis syndromes potentially lessening repeated invasive interventions in affected children. IMPACT: Small intestinal pediatric Peutz-Jeghers polyps express a distinct phosphoproteomic and kinase activation profile when compared with adjacent mucosa. Integrated analysis reveals partial epithelial-mesenchymal transition, cytoskeletal remodeling, and transcriptional amplification as key drivers of polyp growth. Polarity and checkpoint signaling consistent with protective stress adaptation are conserved in non-polyp mucosa. This study is the first phosphoproteomic description of pediatric Peutz-Jeghers syndrome, identifying potential kinase biomarkers and therapeutic targets that could reduce the need for repeated invasive procedures in affected children.
Identifiers
42082734What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.